Article(id=1330225654550868216, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225632362999820, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2022.06.003, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1638288000000, receivedDateStr=2021-12-01, revisedDate=1649692800000, revisedDateStr=2022-04-12, acceptedDate=null, acceptedDateStr=null, onlineDate=1795080110442, onlineDateStr=2026-11-19, pubDate=1654790400000, pubDateStr=2022-06-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795080110442, onlineIssueDateStr=2026-11-19, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795080110442, creator=13701087609, updateTime=1795080110442, updator=13701087609, issue=Issue{id=1330225632362999820, tenantId=1146029695717560320, journalId=1319690329412173987, year='2022', volume='43', issue='6', pageStart='643', pageEnd='810', issueExtLink='null', onlineDate='null', pubDate='1654790400000', pubDateStr='2022-06-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795080105152, creator='13701087609', updateTime=1795084738205, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330245065345184449, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225632362999820, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330245065345184450, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225632362999820, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=663, endPage=670, ext={EN=ArticleExt(id=1330225654748000505, articleId=1330225654550868216, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Comparison of sodium-glucose linked transporter 2 inhibitors approved in China, columnId=1325221107665612978, journalTitle=World Clinical Drug, columnName=Topic, runingTitle=null, highlight=null, articleAbstract=

Sodium-glucose linked transporter 2 (SGLT2) inhibitors are a new class of anti-diabetes mellitus (DM) drugs. SGLT2 is usually involved in the reabsorption of about 90% of the glucose filtered by the glomerular. SGLT2 inhibitors directly reduce blood sugar by inhibiting the active transport of glucose by SGLT2, inhibiting the reabsorption of glucose by the kidneys, increasing urinary glucose excretion. SGLT2 inhibitors are becoming increasingly important in the treatment of type 2 DM (T2DM), as they can not only reduce blood glucose, but also have cardio-renal protective effects. SGLT2 inhibitors have been widely used after being marketed in China. Now, the pharmacokinetic characteristics, hypoglycemic effect, cardiovascular protection, renal protection and adverse reactions of SGLT2 inhibitors that have been listed in China were compared in order to provide reference for clinical medication.

, authors=Xiaoying XU1, Xingyun HOU2, Yuzhen LI1, Nianxi YU2, Jiaoyang ZHENG3, *, authorsList=Xiaoying XU, Xingyun HOU, Yuzhen LI, Nianxi YU, Jiaoyang ZHENG, authorCompany=null, correspAuthors=Jiaoyang ZHENG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1330225654987075834, articleId=1330225654550868216, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=国内上市的钠-葡萄糖耦联转运体2抑制剂的比较, columnId=1325221107824996532, journalTitle=世界临床药物, columnName=医药专论, runingTitle=null, highlight=null, articleAbstract=

钠-葡萄糖耦联转运体2(sodium-glucose linked transporter 2,SGLT2)抑制剂是一类新型降糖药物。SGLT2通常参与约90%经肾小球滤过的葡萄糖的重吸收,SGLT2抑制剂通过抑制SGLT2对葡萄糖的主动运输,抑制肾脏对葡萄糖的重吸收,增加尿糖排泄,从而降低血糖。SGLT2抑制剂不仅可降低血糖,还有心肾保护作用,且在2型糖尿病(type 2 diabetes mellitus,T2DM)的治疗中占据越来越重要的地位。SGLT2抑制剂在中国上市后得到了广泛应用,现对国内已上市的SGLT2抑制剂,从药代动力学特点、降糖效果、心血管保护、肾脏保护及不良反应等方面进行比较,旨在为临床用药提供参考。

, authors=徐小英1, 侯幸赟2, 李玉珍1, 余年喜2, 郑骄阳3, *, authorsList=徐小英, 侯幸赟, 李玉珍, 余年喜, 郑骄阳, authorCompany=null, correspAuthors=郑骄阳, authorNote=

# 对本文贡献等同

徐小英,硕士,主管药师,研究方向:药物分析学、临床药学。

侯幸赟,硕士,主管药师,研究方向:临床药学。

, correspAuthorsNote=
郑骄阳,副教授,博士,副主任医师,研究方向:内分泌疾病用药。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=KC6PXbKabcAvP+nraKOlaA==, magXml=zhQaU6clis+jGyT/IH7TDA==, pdfUrl=null, pdf=eFaruqvBP/NOncNqhT4k0w==, pdfFileSize=1804852, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=6Eoep/UPms+B5cnm7s2xLg==, mapNumber=null, fund=null)}, authors=[Author(id=1330225655410700549, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225655473615111, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, authorId=1330225655410700549, language=EN, stringName=Xiaoying XU, firstName=Xiaoying, middleName=null, lastName=XU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Pharmacy, the Eighth Affiliated Hospital, Sun Yat-Sen University, Shenzhen 518033, Guangdong Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225655540723976, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, authorId=1330225655410700549, language=CN, stringName=徐小英, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中山大学附属第八医院药学部,广东 深圳 518033, bio={"content":"

徐小英,硕士,主管药师,研究方向:药物分析学、临床药学。

"}, bioImg=null, bioContent=

徐小英,硕士,主管药师,研究方向:药物分析学、临床药学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225655163236603, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, xref=1., ext=[AuthorCompanyExt(id=1330225655167430908, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, companyId=1330225655163236603, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, the Eighth Affiliated Hospital, Sun Yat-Sen University, Shenzhen 518033, Guangdong Province, China), AuthorCompanyExt(id=1330225655175819517, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, companyId=1330225655163236603, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中山大学附属第八医院药学部,广东 深圳 518033)])]), Author(id=1330225655607832842, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225655674941708, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, authorId=1330225655607832842, language=EN, stringName=Xingyun HOU, firstName=Xingyun, middleName=null, lastName=HOU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Department of Pharmacy, Second Affiliated Hospital of Naval Medical University, Shanghai 200433, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225655737856269, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, authorId=1330225655607832842, language=CN, stringName=侯幸赟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.海军军医大学第二附属医院药剂科,上海 200433, bio={"content":"

侯幸赟,硕士,主管药师,研究方向:临床药学。

"}, bioImg=null, bioContent=

侯幸赟,硕士,主管药师,研究方向:临床药学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225655238734078, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, xref=2., ext=[AuthorCompanyExt(id=1330225655242928383, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, companyId=1330225655238734078, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Pharmacy, Second Affiliated Hospital of Naval Medical University, Shanghai 200433, China), AuthorCompanyExt(id=1330225655251316992, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, companyId=1330225655238734078, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.海军军医大学第二附属医院药剂科,上海 200433)])]), Author(id=1330225655800770831, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225655884656913, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, authorId=1330225655800770831, language=EN, stringName=Yuzhen LI, firstName=Yuzhen, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Pharmacy, the Eighth Affiliated Hospital, Sun Yat-Sen University, Shenzhen 518033, Guangdong Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225655960154386, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, authorId=1330225655800770831, language=CN, stringName=李玉珍, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中山大学附属第八医院药学部,广东 深圳 518033, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225655163236603, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, xref=1., ext=[AuthorCompanyExt(id=1330225655167430908, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, companyId=1330225655163236603, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, the Eighth Affiliated Hospital, Sun Yat-Sen University, Shenzhen 518033, Guangdong Province, China), AuthorCompanyExt(id=1330225655175819517, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, companyId=1330225655163236603, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中山大学附属第八医院药学部,广东 深圳 518033)])]), Author(id=1330225656018874644, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225656098566422, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, authorId=1330225656018874644, language=EN, stringName=Nianxi YU, firstName=Nianxi, middleName=null, lastName=YU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Department of Pharmacy, Second Affiliated Hospital of Naval Medical University, Shanghai 200433, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225656157286679, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, authorId=1330225656018874644, language=CN, stringName=余年喜, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.海军军医大学第二附属医院药剂科,上海 200433, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225655238734078, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, xref=2., ext=[AuthorCompanyExt(id=1330225655242928383, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, companyId=1330225655238734078, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Pharmacy, Second Affiliated Hospital of Naval Medical University, Shanghai 200433, China), AuthorCompanyExt(id=1330225655251316992, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, companyId=1330225655238734078, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.海军军医大学第二附属医院药剂科,上海 200433)])]), Author(id=1330225656236978457, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330225656341836059, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, authorId=1330225656236978457, language=EN, stringName=Jiaoyang ZHENG, firstName=Jiaoyang, middleName=null, lastName=ZHENG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, *, address=3.Department of Health Management, Second Affiliated Hospital of Naval Medical University, Shanghai 200433, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225656434110748, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, authorId=1330225656236978457, language=CN, stringName=郑骄阳, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, *, address=3.海军军医大学第二附属医院健康管理科,上海 200433, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225655331008769, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, xref=3., ext=[AuthorCompanyExt(id=1330225655339397378, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, companyId=1330225655331008769, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Department of Health Management, Second Affiliated Hospital of Naval Medical University, Shanghai 200433, China), AuthorCompanyExt(id=1330225655347785987, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, companyId=1330225655331008769, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.海军军医大学第二附属医院健康管理科,上海 200433)])])], keywords=[Keyword(id=1330225656517996829, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, language=EN, orderNo=1, keyword=sodium-glucose linked transporter 2 inhibitor), Keyword(id=1330225656593494302, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, language=EN, orderNo=2, keyword=dapagliflozin), Keyword(id=1330225656664797471, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, language=EN, orderNo=3, keyword=empagliflozin), Keyword(id=1330225656731906336, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, language=EN, orderNo=4, keyword=canagliflozin), Keyword(id=1330225656786432289, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, language=EN, orderNo=5, keyword=ertugliflozin), Keyword(id=1330225656853541154, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, language=CN, orderNo=1, keyword=钠-葡萄糖耦联转运体2抑制剂), Keyword(id=1330225656908067107, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, language=CN, orderNo=2, keyword=达格列净), Keyword(id=1330225656970981668, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, language=CN, orderNo=3, keyword=恩格列净), Keyword(id=1330225657033896229, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, language=CN, orderNo=4, keyword=卡格列净), Keyword(id=1330225657088422182, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, language=CN, orderNo=5, keyword=艾托格列净)], refs=[Reference(id=1330225657344274729, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=International Diabetes Federation. IDF Diabetes Atlas[EB/OL]. [2021-11-01]. https://diabetesatlas.org/en/., articleTitle=null, refAbstract=null), Reference(id=1330225657520435498, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=Ma RCW. Epidemiology of diabetes and diabetic complications in China[J]. Diabetologia, 2018, 61(6): 1249-1260., articleTitle=null, refAbstract=null), Reference(id=1330225657633681707, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=王丽, 赵振宇, 杨晨. 钠-葡萄糖协同转运蛋白2抑制剂的作用机制及研究进展[J]. 中国药房, 2015, 26(28): 4003-4006., articleTitle=null, refAbstract=null), Reference(id=1330225657713373484, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Ghezzi C, Loo DDF, Wright EM. Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2[J]. Diabetologia, 2018, 61(10): 2087-2097., articleTitle=null, refAbstract=null), Reference(id=1330225657814036781, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Marsenic O. Glucose control by the kidney: an emerging target in diabetes[J]. Am J Kidney Dis, 2009, 53(5): 875-883., articleTitle=null, refAbstract=null), Reference(id=1330225657885339950, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Gerich JE. Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications[J]. Diabet Med, 2010, 27(2): 136-142., articleTitle=null, refAbstract=null), Reference(id=1330225657973420335, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=DeFronzo RA, Hompesch M, Kasichayanula S, et al. Characterization of renal glucose reabsorption in response to dapagliflozin in healthy subjects and subjects with type 2 diabetes[J]. Diabetes Care, 2013, 36(10): 3169-3176., articleTitle=null, refAbstract=null), Reference(id=1330225658053112112, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Ehrenkranz JR, Lewis NG, Kahn CR, et al. Phlorizin: a review[J]. Diabetes Metab Res Rev, 2005, 21(1): 31-38., articleTitle=null, refAbstract=null), Reference(id=1330225658107638065, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Mudaliar S, Polidori D, Zambrowicz B, et al. Sodium-glucose cotransporter inhibitors: effects on renal and intestinal glucose transport[J]. Diabetes Care, 2015, 38(12): 2344-2353., articleTitle=null, refAbstract=null), Reference(id=1330225658170552626, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=谢少斐, 张凤逸, 邹珊, 等. 已上市钠-葡萄糖协同转运蛋白2抑制剂临床药动学特点比较[J]. 中国现代应用药学, 2016, 33(4): 517-520., articleTitle=null, refAbstract=null), Reference(id=1330225658229272883, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Scheen AJ. Pharmacodynamics, efficacy and safety of sodium-glucose co-transporter type 2 (SGLT2) inhibitors for the treatment of type 2 diabetes mellitus[J]. Drugs, 2015, 75(1): 33-59., articleTitle=null, refAbstract=null), Reference(id=1330225658292187444, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Fediuk DJ, Nucci G, Dawra VK, et al. Overview of the clinical pharmacology of ertugliflozin, a novel sodium-glucose cotransporter 2 (SGLT2) inhibitor[J]. Clin Pharmacokinet, 2020, 59(8): 949-965., articleTitle=null, refAbstract=null), Reference(id=1330225658384462133, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Kasichayanula S, Liu X, Lacreta F, et al. Clinical pharmacokinetics and pharmacodynamics of dapagliflozin, a selective inhibitor of sodium-glucose co-transporter type 2[J]. Clin Pharmacokinet, 2014, 53(1): 17-27., articleTitle=null, refAbstract=null), Reference(id=1330225658468348214, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Rosenthal N, Meininger G, Ways K, et al. Canagliflozin: a sodium glucose co-transporter 2 inhibitor for the treatment of type 2 diabetes mellitus[J]. Ann NY Acad Sci, 2015, 1358: 28-43., articleTitle=null, refAbstract=null), Reference(id=1330225658535457079, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=孙永, 田琳, 吴让兵, 等. 2型糖尿病治疗新药恩格列净的研究现状[J]. 中国糖尿病杂志, 2018, 26(6): 523-528., articleTitle=null, refAbstract=null), Reference(id=1330225658594177336, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Scheen AJ. Pharmacokinetic and pharmacodynamic profile of empagliflozin, a sodium glucose co-transporter 2 inhibitor[J]. Clin Pharmacokinet, 2014, 53(3): 213-225., articleTitle=null, refAbstract=null), Reference(id=1330225658652897593, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Johnston R, Uthman O, Cummins E, et al. Canagliflozin, dapagliflozin and empagliflozin monotherapy for treating type 2 diabetes: systematic review and economic evaluation[J]. Health Technol Assess, 2017, 21(2): 1-218., articleTitle=null, refAbstract=null), Reference(id=1330225658707423546, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Hu J, Deng A, Zhao Y. Ertugliflozin as a monotherapy for the treatment of type 2 diabetes[J]. Expert Opin Pharmacother, 2018, 19(16): 1841-1847., articleTitle=null, refAbstract=null), Reference(id=1330225658761949499, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Polidori D, Sha S, Mudaliar S, et al. Canagliflflozin lowers postprandial glucose and insulin by delaying intestinal glucose absorption in addition to increasing urinary glucose excretion: results of a randomized, placebo-controlled study[J]. Diabetes Care, 2013, 36(8): 2154-2161., articleTitle=null, refAbstract=null), Reference(id=1330225658824864060, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Devineni D, Curtin CR, Polidori D, et al. Pharmacokinetics and pharmacodynamics of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in subjects with type 2 diabetes mellitus[J]. J Clin Pharmacol, 2013, 53(6): 601-610., articleTitle=null, refAbstract=null), Reference(id=1330225658887778621, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Komoroski B, Vachharajani N, Feng Y, et al. Dapagliflozin, a novel, selective SGLT2 inhibitor, improved glycemic control over 2 weeks in patients with type 2 diabetes mellitus[J]. Clin Pharmacol Ther, 2009, 85(5): 513-519., articleTitle=null, refAbstract=null), Reference(id=1330225658938110270, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Heise T, Seewaldt-Becker E, Macha S, et al. Safety, tolerability, pharmacokinetics and pharmacodynamics following 4 weeks' treatment with empagliflozin once daily in patients with type 2 diabetes[J]. Diabetes Obes Metab, 2013, 15(7): 613-621., articleTitle=null, refAbstract=null), Reference(id=1330225659005219135, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=Dawra VK, Liang Y, Shi H, et al. A PK/PD study comparing twice-daily to once-daily dosing regimens of ertugliflozin in healthy subjects[J]. Int J Clin Pharmacol Ther, 2019, 57(4): 207-216., articleTitle=null, refAbstract=null), Reference(id=1330225659059745088, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=Wiviott SD, Raz I, Bonaca MP, et al. Dapagliflozin and cardiovascular outcomes in type 2 diabetes[J]. N Engl J Med, 2019, 380(4): 347-357., articleTitle=null, refAbstract=null), Reference(id=1330225659122659649, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=Neal B, Perkovic V, Mahaffey KW, et al. Canagliflozin and cardiovascular and renal events in type 2 diabetes[J]. N Engl J Med, 2017, 377(7): 644-657., articleTitle=null, refAbstract=null), Reference(id=1330225659185574210, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=Zinman B, Wanner C, Lachin JM, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes[J]. N Engl J Med, 2015, 373(22): 2117-2128., articleTitle=null, refAbstract=null), Reference(id=1330225659256877379, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=Cannon CP, Pratley R, Dagogo-Jack S, et al. VERTIS CV investigators. Cardiovascular outcomes with ertugliflozin in type 2 diabetes[J]. N Engl J Med, 2020, 383(15): 1425-1435., articleTitle=null, refAbstract=null), Reference(id=1330225659315597636, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=蒋昭隆, 刘剑雄. SGLT2抑制剂在2型糖尿病患者心血管获益机制[J]. 海南医学, 2019, 30(19): 2557-2560., articleTitle=null, refAbstract=null), Reference(id=1330225659374317893, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=Zelniker TA, Wiviott SD, Raz I, et al. SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials[J]. Lancet, 2019, 393(10166): 31-39., articleTitle=null, refAbstract=null), Reference(id=1330225659437232454, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=Scheen AJ. An update on the safety of SGLT2 inhibitors[J]. Expert Opin Drug Saf, 2019, 18(4): 295-311., articleTitle=null, refAbstract=null), Reference(id=1330225659516924231, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=刘瑞红, 毕然然, 王绵, 等. 钠-葡萄糖协同转运蛋白2抑制剂治疗1型糖尿病的研究进展[J]. 中国糖尿病杂志, 2019, 27(11): 874-876., articleTitle=null, refAbstract=null), Reference(id=1330225659584033096, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=Chen J, Fan F, Wang JY, et al. The efficacy and safety of SGLT2 inhibitors for adjunctive treatment of type 1 diabetes: a systematic review and meta-analysis[J]. Sci Rep, 2017, 7: 44128., articleTitle=null, refAbstract=null), Reference(id=1330225659646947657, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=Taylor SI, Blau JE, Rother KI, et al. SGLT2 inhibitors as adjunctive therapy for type 1 diabetes: balancing benefits and risks[J]. Lancet Diabetes Endocrinol, 2019, 7(12): 949-958., articleTitle=null, refAbstract=null), Reference(id=1330225659714056522, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=McMurray JJV, Solomon SD, Inzucchi SE, et al. Dapagliflozin in patients with heart failure and reduced ejection fraction[J]. N Engl J Med, 2019, 381(21): 1995-2008., articleTitle=null, refAbstract=null)], funds=[Fund(id=1330225657180696871, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, awardId=20194Y0035, language=CN, fundingSource=上海市卫生健康委员会青年课题(20194Y0035), fundOrder=null, country=null), Fund(id=1330225657247805736, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, awardId=null, language=CN, fundingSource=上海市“医苑新星”青年医学人才培养资助计划(青年医学人才类——临床药师项目), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1330225655163236603, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, xref=1., ext=[AuthorCompanyExt(id=1330225655167430908, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, companyId=1330225655163236603, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, the Eighth Affiliated Hospital, Sun Yat-Sen University, Shenzhen 518033, Guangdong Province, China), AuthorCompanyExt(id=1330225655175819517, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, companyId=1330225655163236603, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中山大学附属第八医院药学部,广东 深圳 518033)]), AuthorCompany(id=1330225655238734078, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, xref=2., ext=[AuthorCompanyExt(id=1330225655242928383, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, companyId=1330225655238734078, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Pharmacy, Second Affiliated Hospital of Naval Medical University, Shanghai 200433, China), AuthorCompanyExt(id=1330225655251316992, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, companyId=1330225655238734078, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.海军军医大学第二附属医院药剂科,上海 200433)]), AuthorCompany(id=1330225655331008769, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, xref=3., ext=[AuthorCompanyExt(id=1330225655339397378, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, companyId=1330225655331008769, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Department of Health Management, Second Affiliated Hospital of Naval Medical University, Shanghai 200433, China), AuthorCompanyExt(id=1330225655347785987, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, companyId=1330225655331008769, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.海军军医大学第二附属医院健康管理科,上海 200433)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2022.06.003, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.06.003, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2022.06.003, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2022.06.003, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1654790400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
国内上市的钠-葡萄糖耦联转运体2抑制剂的比较
徐小英 1 , 侯幸赟 2 , 李玉珍 1 , 余年喜 2 , 郑骄阳 3, *
世界临床药物 | 医药专论 2022,43(6): 663-670
收起
收藏切换
世界临床药物 |医药专论 2022 , 43 (6) : 663 -670
国内上市的钠-葡萄糖耦联转运体2抑制剂的比较
全屏
[Author(id=1330225655410700549, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225655473615111, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, authorId=1330225655410700549, language=EN, stringName=Xiaoying XU, firstName=Xiaoying, middleName=null, lastName=XU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Pharmacy, the Eighth Affiliated Hospital, Sun Yat-Sen University, Shenzhen 518033, Guangdong Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225655540723976, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, authorId=1330225655410700549, language=CN, stringName=徐小英, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中山大学附属第八医院药学部,广东 深圳 518033, bio={"content":"

徐小英,硕士,主管药师,研究方向:药物分析学、临床药学。

"}, bioImg=null, bioContent=

徐小英,硕士,主管药师,研究方向:药物分析学、临床药学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225655163236603, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, xref=1., ext=[AuthorCompanyExt(id=1330225655167430908, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, companyId=1330225655163236603, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, the Eighth Affiliated Hospital, Sun Yat-Sen University, Shenzhen 518033, Guangdong Province, China), AuthorCompanyExt(id=1330225655175819517, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, companyId=1330225655163236603, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中山大学附属第八医院药学部,广东 深圳 518033)])]), Author(id=1330225655607832842, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225655674941708, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, authorId=1330225655607832842, language=EN, stringName=Xingyun HOU, firstName=Xingyun, middleName=null, lastName=HOU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Department of Pharmacy, Second Affiliated Hospital of Naval Medical University, Shanghai 200433, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225655737856269, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, authorId=1330225655607832842, language=CN, stringName=侯幸赟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.海军军医大学第二附属医院药剂科,上海 200433, bio={"content":"

侯幸赟,硕士,主管药师,研究方向:临床药学。

"}, bioImg=null, bioContent=

侯幸赟,硕士,主管药师,研究方向:临床药学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225655238734078, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, xref=2., ext=[AuthorCompanyExt(id=1330225655242928383, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, companyId=1330225655238734078, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Pharmacy, Second Affiliated Hospital of Naval Medical University, Shanghai 200433, China), AuthorCompanyExt(id=1330225655251316992, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, companyId=1330225655238734078, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.海军军医大学第二附属医院药剂科,上海 200433)])]), Author(id=1330225655800770831, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225655884656913, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, authorId=1330225655800770831, language=EN, stringName=Yuzhen LI, firstName=Yuzhen, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Pharmacy, the Eighth Affiliated Hospital, Sun Yat-Sen University, Shenzhen 518033, Guangdong Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225655960154386, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, authorId=1330225655800770831, language=CN, stringName=李玉珍, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中山大学附属第八医院药学部,广东 深圳 518033, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225655163236603, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, xref=1., ext=[AuthorCompanyExt(id=1330225655167430908, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, companyId=1330225655163236603, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, the Eighth Affiliated Hospital, Sun Yat-Sen University, Shenzhen 518033, Guangdong Province, China), AuthorCompanyExt(id=1330225655175819517, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, companyId=1330225655163236603, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中山大学附属第八医院药学部,广东 深圳 518033)])]), Author(id=1330225656018874644, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225656098566422, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, authorId=1330225656018874644, language=EN, stringName=Nianxi YU, firstName=Nianxi, middleName=null, lastName=YU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Department of Pharmacy, Second Affiliated Hospital of Naval Medical University, Shanghai 200433, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225656157286679, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, authorId=1330225656018874644, language=CN, stringName=余年喜, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.海军军医大学第二附属医院药剂科,上海 200433, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225655238734078, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, xref=2., ext=[AuthorCompanyExt(id=1330225655242928383, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, companyId=1330225655238734078, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Pharmacy, Second Affiliated Hospital of Naval Medical University, Shanghai 200433, China), AuthorCompanyExt(id=1330225655251316992, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, companyId=1330225655238734078, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.海军军医大学第二附属医院药剂科,上海 200433)])]), Author(id=1330225656236978457, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330225656341836059, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, authorId=1330225656236978457, language=EN, stringName=Jiaoyang ZHENG, firstName=Jiaoyang, middleName=null, lastName=ZHENG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, *, address=3.Department of Health Management, Second Affiliated Hospital of Naval Medical University, Shanghai 200433, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225656434110748, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, authorId=1330225656236978457, language=CN, stringName=郑骄阳, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, *, address=3.海军军医大学第二附属医院健康管理科,上海 200433, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225655331008769, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, xref=3., ext=[AuthorCompanyExt(id=1330225655339397378, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, companyId=1330225655331008769, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Department of Health Management, Second Affiliated Hospital of Naval Medical University, Shanghai 200433, China), AuthorCompanyExt(id=1330225655347785987, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225654550868216, companyId=1330225655331008769, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.海军军医大学第二附属医院健康管理科,上海 200433)])])]
徐小英1, 侯幸赟2, 李玉珍1, 余年喜2, 郑骄阳3, *
作者信息
  • 1.中山大学附属第八医院药学部,广东 深圳 518033
  • 2.海军军医大学第二附属医院药剂科,上海 200433
  • 3.海军军医大学第二附属医院健康管理科,上海 200433
通讯作者:
郑骄阳,副教授,博士,副主任医师,研究方向:内分泌疾病用药。
作者简介:

# 对本文贡献等同

徐小英,硕士,主管药师,研究方向:药物分析学、临床药学。

侯幸赟,硕士,主管药师,研究方向:临床药学。

Comparison of sodium-glucose linked transporter 2 inhibitors approved in China
Xiaoying XU1, Xingyun HOU2, Yuzhen LI1, Nianxi YU2, Jiaoyang ZHENG3, *
Affiliations
  • 1.Department of Pharmacy, the Eighth Affiliated Hospital, Sun Yat-Sen University, Shenzhen 518033, Guangdong Province, China
  • 2.Department of Pharmacy, Second Affiliated Hospital of Naval Medical University, Shanghai 200433, China
  • 3.Department of Health Management, Second Affiliated Hospital of Naval Medical University, Shanghai 200433, China
出版时间: 2022-06-10 doi: 10.13683/j.wph.2022.06.003
文章导航
收藏切换

钠-葡萄糖耦联转运体2(sodium-glucose linked transporter 2,SGLT2)抑制剂是一类新型降糖药物。SGLT2通常参与约90%经肾小球滤过的葡萄糖的重吸收,SGLT2抑制剂通过抑制SGLT2对葡萄糖的主动运输,抑制肾脏对葡萄糖的重吸收,增加尿糖排泄,从而降低血糖。SGLT2抑制剂不仅可降低血糖,还有心肾保护作用,且在2型糖尿病(type 2 diabetes mellitus,T2DM)的治疗中占据越来越重要的地位。SGLT2抑制剂在中国上市后得到了广泛应用,现对国内已上市的SGLT2抑制剂,从药代动力学特点、降糖效果、心血管保护、肾脏保护及不良反应等方面进行比较,旨在为临床用药提供参考。

钠-葡萄糖耦联转运体2抑制剂  /  达格列净  /  恩格列净  /  卡格列净  /  艾托格列净

Sodium-glucose linked transporter 2 (SGLT2) inhibitors are a new class of anti-diabetes mellitus (DM) drugs. SGLT2 is usually involved in the reabsorption of about 90% of the glucose filtered by the glomerular. SGLT2 inhibitors directly reduce blood sugar by inhibiting the active transport of glucose by SGLT2, inhibiting the reabsorption of glucose by the kidneys, increasing urinary glucose excretion. SGLT2 inhibitors are becoming increasingly important in the treatment of type 2 DM (T2DM), as they can not only reduce blood glucose, but also have cardio-renal protective effects. SGLT2 inhibitors have been widely used after being marketed in China. Now, the pharmacokinetic characteristics, hypoglycemic effect, cardiovascular protection, renal protection and adverse reactions of SGLT2 inhibitors that have been listed in China were compared in order to provide reference for clinical medication.

sodium-glucose linked transporter 2 inhibitor  /  dapagliflozin  /  empagliflozin  /  canagliflozin  /  ertugliflozin
徐小英, 侯幸赟, 李玉珍, 余年喜, 郑骄阳. 国内上市的钠-葡萄糖耦联转运体2抑制剂的比较. 世界临床药物, 2022 , 43 (6) : 663 -670 . DOI: 10.13683/j.wph.2022.06.003
Xiaoying XU, Xingyun HOU, Yuzhen LI, Nianxi YU, Jiaoyang ZHENG. Comparison of sodium-glucose linked transporter 2 inhibitors approved in China[J]. World Clinical Drug, 2022 , 43 (6) : 663 -670 . DOI: 10.13683/j.wph.2022.06.003
  • 上海市卫生健康委员会青年课题(20194Y0035)
  • 上海市“医苑新星”青年医学人才培养资助计划(青年医学人才类——临床药师项目)
参考文献 引证文献
排序方式:
[1]
International Diabetes Federation. IDF Diabetes Atlas[EB/OL]. [2021-11-01]. https://diabetesatlas.org/en/.
[2]
Ma RCW. Epidemiology of diabetes and diabetic complications in China[J]. Diabetologia, 2018, 61(6): 1249-1260.
[3]
王丽, 赵振宇, 杨晨. 钠-葡萄糖协同转运蛋白2抑制剂的作用机制及研究进展[J]. 中国药房, 2015, 26(28): 4003-4006.
[4]
Ghezzi C, Loo DDF, Wright EM. Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2[J]. Diabetologia, 2018, 61(10): 2087-2097.
[5]
Marsenic O. Glucose control by the kidney: an emerging target in diabetes[J]. Am J Kidney Dis, 2009, 53(5): 875-883.
[6]
Gerich JE. Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications[J]. Diabet Med, 2010, 27(2): 136-142.
[7]
DeFronzo RA, Hompesch M, Kasichayanula S, et al. Characterization of renal glucose reabsorption in response to dapagliflozin in healthy subjects and subjects with type 2 diabetes[J]. Diabetes Care, 2013, 36(10): 3169-3176.
[8]
Ehrenkranz JR, Lewis NG, Kahn CR, et al. Phlorizin: a review[J]. Diabetes Metab Res Rev, 2005, 21(1): 31-38.
[9]
Mudaliar S, Polidori D, Zambrowicz B, et al. Sodium-glucose cotransporter inhibitors: effects on renal and intestinal glucose transport[J]. Diabetes Care, 2015, 38(12): 2344-2353.
[10]
谢少斐, 张凤逸, 邹珊, 等. 已上市钠-葡萄糖协同转运蛋白2抑制剂临床药动学特点比较[J]. 中国现代应用药学, 2016, 33(4): 517-520.
[11]
Scheen AJ. Pharmacodynamics, efficacy and safety of sodium-glucose co-transporter type 2 (SGLT2) inhibitors for the treatment of type 2 diabetes mellitus[J]. Drugs, 2015, 75(1): 33-59.
[12]
Fediuk DJ, Nucci G, Dawra VK, et al. Overview of the clinical pharmacology of ertugliflozin, a novel sodium-glucose cotransporter 2 (SGLT2) inhibitor[J]. Clin Pharmacokinet, 2020, 59(8): 949-965.
[13]
Kasichayanula S, Liu X, Lacreta F, et al. Clinical pharmacokinetics and pharmacodynamics of dapagliflozin, a selective inhibitor of sodium-glucose co-transporter type 2[J]. Clin Pharmacokinet, 2014, 53(1): 17-27.
[14]
Rosenthal N, Meininger G, Ways K, et al. Canagliflozin: a sodium glucose co-transporter 2 inhibitor for the treatment of type 2 diabetes mellitus[J]. Ann NY Acad Sci, 2015, 1358: 28-43.
[15]
孙永, 田琳, 吴让兵, 等. 2型糖尿病治疗新药恩格列净的研究现状[J]. 中国糖尿病杂志, 2018, 26(6): 523-528.
[16]
Scheen AJ. Pharmacokinetic and pharmacodynamic profile of empagliflozin, a sodium glucose co-transporter 2 inhibitor[J]. Clin Pharmacokinet, 2014, 53(3): 213-225.
[17]
Johnston R, Uthman O, Cummins E, et al. Canagliflozin, dapagliflozin and empagliflozin monotherapy for treating type 2 diabetes: systematic review and economic evaluation[J]. Health Technol Assess, 2017, 21(2): 1-218.
[18]
Hu J, Deng A, Zhao Y. Ertugliflozin as a monotherapy for the treatment of type 2 diabetes[J]. Expert Opin Pharmacother, 2018, 19(16): 1841-1847.
[19]
Polidori D, Sha S, Mudaliar S, et al. Canagliflflozin lowers postprandial glucose and insulin by delaying intestinal glucose absorption in addition to increasing urinary glucose excretion: results of a randomized, placebo-controlled study[J]. Diabetes Care, 2013, 36(8): 2154-2161.
[20]
Devineni D, Curtin CR, Polidori D, et al. Pharmacokinetics and pharmacodynamics of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in subjects with type 2 diabetes mellitus[J]. J Clin Pharmacol, 2013, 53(6): 601-610.
[21]
Komoroski B, Vachharajani N, Feng Y, et al. Dapagliflozin, a novel, selective SGLT2 inhibitor, improved glycemic control over 2 weeks in patients with type 2 diabetes mellitus[J]. Clin Pharmacol Ther, 2009, 85(5): 513-519.
[22]
Heise T, Seewaldt-Becker E, Macha S, et al. Safety, tolerability, pharmacokinetics and pharmacodynamics following 4 weeks' treatment with empagliflozin once daily in patients with type 2 diabetes[J]. Diabetes Obes Metab, 2013, 15(7): 613-621.
[23]
Dawra VK, Liang Y, Shi H, et al. A PK/PD study comparing twice-daily to once-daily dosing regimens of ertugliflozin in healthy subjects[J]. Int J Clin Pharmacol Ther, 2019, 57(4): 207-216.
[24]
Wiviott SD, Raz I, Bonaca MP, et al. Dapagliflozin and cardiovascular outcomes in type 2 diabetes[J]. N Engl J Med, 2019, 380(4): 347-357.
[25]
Neal B, Perkovic V, Mahaffey KW, et al. Canagliflozin and cardiovascular and renal events in type 2 diabetes[J]. N Engl J Med, 2017, 377(7): 644-657.
[26]
Zinman B, Wanner C, Lachin JM, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes[J]. N Engl J Med, 2015, 373(22): 2117-2128.
[27]
Cannon CP, Pratley R, Dagogo-Jack S, et al. VERTIS CV investigators. Cardiovascular outcomes with ertugliflozin in type 2 diabetes[J]. N Engl J Med, 2020, 383(15): 1425-1435.
[28]
蒋昭隆, 刘剑雄. SGLT2抑制剂在2型糖尿病患者心血管获益机制[J]. 海南医学, 2019, 30(19): 2557-2560.
[29]
Zelniker TA, Wiviott SD, Raz I, et al. SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials[J]. Lancet, 2019, 393(10166): 31-39.
[30]
Scheen AJ. An update on the safety of SGLT2 inhibitors[J]. Expert Opin Drug Saf, 2019, 18(4): 295-311.
[31]
刘瑞红, 毕然然, 王绵, 等. 钠-葡萄糖协同转运蛋白2抑制剂治疗1型糖尿病的研究进展[J]. 中国糖尿病杂志, 2019, 27(11): 874-876.
[32]
Chen J, Fan F, Wang JY, et al. The efficacy and safety of SGLT2 inhibitors for adjunctive treatment of type 1 diabetes: a systematic review and meta-analysis[J]. Sci Rep, 2017, 7: 44128.
[33]
Taylor SI, Blau JE, Rother KI, et al. SGLT2 inhibitors as adjunctive therapy for type 1 diabetes: balancing benefits and risks[J]. Lancet Diabetes Endocrinol, 2019, 7(12): 949-958.
[34]
McMurray JJV, Solomon SD, Inzucchi SE, et al. Dapagliflozin in patients with heart failure and reduced ejection fraction[J]. N Engl J Med, 2019, 381(21): 1995-2008.
2022年第43卷第6期
16
4
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2022.06.003
  • 接收时间:2021-12-01
  • 首发时间:2026-11-19
  • 出版时间:2022-06-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2021-12-01
  • 修回日期:2022-04-12
基金
上海市卫生健康委员会青年课题(20194Y0035)
上海市“医苑新星”青年医学人才培养资助计划(青年医学人才类——临床药师项目)
作者信息
    1.中山大学附属第八医院药学部,广东 深圳 518033
    2.海军军医大学第二附属医院药剂科,上海 200433
    3.海军军医大学第二附属医院健康管理科,上海 200433

通讯作者:

郑骄阳,副教授,博士,副主任医师,研究方向:内分泌疾病用药。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2022.06.003
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏